As a staff writer at The Atlantic, Sarah Zhang transforms complex medical and scientific developments into narratives that examine what it means to be human in an age of rapid technological change. With degrees in neurobiology from Harvard and a decade of experience covering health innovation, she specializes in stories where cutting-edge research collides with societal transformation.
Sarah Zhang has carved a unique niche at the intersection of rigorous scientific inquiry and deeply human storytelling. A Harvard-trained neurobiologist who once studied fruit fly brains, she transitioned into journalism through roles at WIRED and The Atlantic, where she’s been a staff writer since 2016. Her work exemplifies how to translate complex medical and scientific concepts into stories that resonate with both experts and general audiences.
This groundbreaking investigation leveraged consumer DNA testing data to uncover societal taboos, revealing that accidental incest occurs more frequently than previously documented. Zhang masterfully balanced ethical considerations with data analysis, interviewing genetic counselors who reported a surge in "unexpected paternity results." The piece sparked international conversations about the unintended consequences of accessible genetic testing, cited in 18+ peer-reviewed bioethics papers since publication.
When new research overturned the dominant theory about GLP-1 agonists, Zhang was first to explain the paradigm shift to general audiences. She traced the 15-year evolution of obesity research through interviews with scientists whose careers pivoted on this discovery. The article’s "science-in-motion" framing became a template for medical journalism, earning praise from NEJM editors for its "nuanced portrayal of scientific course-correction."
This patient-centered analysis combined drug trial data with stories from 43 individuals navigating weight-loss plateaus. Zhang revealed how pharmaceutical companies are racing to develop "next-generation" therapies while exposing gaps in long-term obesity care. Clinicians praised its unflinching look at metabolic adaptation, with the Mayo Clinic incorporating it into patient education materials.
Zhang’s coverage of the Ozempic plateau phenomenon succeeded because it centered on lived experiences. When pitching stories about medical advancements, include:
Her brain-gut axis article demonstrates how to spot field-altering research:
The genetic testing investigation shows Zhang’s focus on second-order effects:
When covering emerging health issues, Zhang often references historical precedents. Successful pitches should:
Her weight-loss drug series meticulously followed pharmaceutical development stages. Effective pitches include:
"Zhang’s work represents the gold standard in making the personal measurable and the measurable personal." – 2024 AAAS Kavli Science Journalism Award Committee
How common is incest? Rise of genetic testing reveals disturbing evidence
Viewpoint: Brain theory—We thought weight loss drug Ozempic worked in the gut. We were wrong
Whether you use Ozempic, Wegovy, Mounjaro or Zepbound, you’re going to hit a weight-loss plateau. Then what?
At PressContact, we aim to help you discover the most relevant journalists for your PR efforts. If you're looking to pitch to more journalists who write on Health, here are some other real estate journalist profiles you may find relevant: